SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-001840
Filing Date
2024-02-27
Accepted
2024-02-27 16:15:19
Documents
14
Period of Report
2024-02-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20240226x8k.htm   iXBRL 8-K 49673
  Complete submission text file 0001558370-24-001840.txt   169806

Data Files

Seq Description Document Type Size
2 EX-101.SCH tmb-20240226.xsd EX-101.SCH 3112
3 EX-101.LAB tmb-20240226_lab.xml EX-101.LAB 15918
4 EX-101.PRE tmb-20240226_pre.xml EX-101.PRE 10044
15 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240226x8k_htm.xml XML 4848
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

IRS No.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 24686925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)